PFM Health Sciences, LP
CIK 1442756 · View on SEC EDGAR ↗
- Portfolio value
- $1.2B
- Positions
- 98
- As of
- June 30, 2026
Portfolio value QoQ: +6.3% 13F does not disclose cash
- Top 10 holdings weight
- 33.90%
- Top 25 holdings weight
- 57.76%
- Positions above 1%
- 37
- Effective number of positions
- 51.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 36.65% Est. buys $414,494,418 · sells $462,871,790
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 49.5% still held
- New positions
- 35
- Increased
- 22
- Decreased
- 41
- Closed
- 15
Put-notional exposure: 0.5% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +36.0% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 96.3% · Options excluded: 9.0%
Sector breakdown
Full portfolio 98 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: K08588103) | $62,191,369 | 5.34% | 233,171 | Up ×1 | |||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $53,750,513 | 4.61% | 219,596 | $9,077,851 | Down ×1 | ||
| LLY Eli Lilly and Company Common Stock | $47,087,223 | 4.04% | 39,258 | $-13,398,692 | Down ×6 | ||
| JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | $38,740,265 | 3.32% | 160,768 | $5,062,142 | Down ×1 | ||
| HUM Humana Inc. Common Stock | $37,487,638 | 3.22% | 94,375 | ||||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $36,690,154 | 3.15% | 88,276 | $20,985,652 | Up ×2 | ||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $35,966,549 | 3.09% | 213,407 | $7,553,129 | Down ×1 | ||
| INBX Inhibrx Biosciences, Inc. - Common Stock | $29,219,479 | 2.51% | 308,385 | $8,685,353 | Up ×3 | ||
| UTHR United Therapeutics Corporation - Common Stock | $27,086,624 | 2.32% | 49,991 | $3,483,055 | Up ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $26,822,616 | 2.30% | 143,222 | $13,132,733 | Up ×1 | ||
| ICLR ICON plc - Ordinary Shares | $23,708,288 | 2.03% | 136,482 | $17,345,338 | Up ×1 | ||
| THC Tenet Healthcare Corporation Common Stock | $23,679,090 | 2.03% | 126,572 | $-51,534,489 | Down ×1 | ||
| EW Edwards Lifesciences Corporation Common Stock | $22,655,978 | 1.94% | 250,453 | $2,274,817 | Down ×1 | ||
| WAT Waters Corporation Common Stock | $22,436,768 | 1.93% | 59,825 | $10,595,347 | Up ×1 | ||
| PEN Penumbra, Inc. Common Stock | $19,014,781 | 1.63% | 60,221 | $-26,884,449 | Down ×3 | ||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $18,870,104 | 1.62% | 253,358 | $-270,188 | Down ×5 | ||
| SYK Stryker Corporation Common Stock | $17,831,593 | 1.53% | 56,637 | $10,616,742 | Up ×1 | ||
| MTD Mettler-Toledo International, Inc. Common Stock | $17,047,093 | 1.46% | 13,344 | Up ×1 | |||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $16,461,564 | 1.41% | 401,208 | $-1,054,256 | Down ×1 | ||
| MRK Merck & Company, Inc. Common Stock (new) | $16,334,663 | 1.40% | 127,118 | ||||
| CYTK Cytokinetics, Incorporated - Common Stock | $16,329,730 | 1.40% | 191,686 | Up ×1 | |||
| LNTH Lantheus Holdings, Inc. - Common Stock | $16,241,949 | 1.39% | 146,403 | Up ×1 | |||
| CNC Centene Corporation Common Stock | $15,974,773 | 1.37% | 248,867 | $7,348,241 | Down ×2 | ||
| COO The Cooper Companies, Inc. - Common Stock | $15,840,022 | 1.36% | 220,890 | $3,697,248 | Up ×3 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $15,739,615 | 1.35% | 29,313 | $-2,134,792 | Down ×1 | ||
| ACHC Acadia Healthcare Company, Inc. - Common Stock | $15,501,301 | 1.33% | 524,934 | $1,870,895 | Down ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $15,115,375 | 1.30% | 158,825 | $6,578,124 | Down ×1 | ||
| OSCR Oscar Health, Inc. Class A Common Stock | $14,802,336 | 1.27% | 519,016 | $9,069,206 | Up ×1 | ||
| TMO Thermo Fisher Scientific Inc Common Stock | $14,286,755 | 1.23% | 28,496 | $6,996,382 | Up ×1 | ||
| CVS CVS Health Corporation Common Stock | $14,219,927 | 1.22% | 137,457 | ||||
| MMSI Merit Medical Systems, Inc. - Common Stock | $13,662,615 | 1.17% | 197,038 | $2,463,627 | Up ×1 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $12,914,524 | 1.11% | 38,575 | $1,496,755 | Up ×2 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $12,753,765 | 1.09% | 342,751 | $2,446,129 | Up ×2 | ||
| NVO Novo Nordisk A/S Common Stock | $12,704,867 | 1.09% | 265,016 | $5,458,465 | Up ×1 | ||
| ITGR Integer Holdings Corporation Common Stock | $11,837,218 | 1.02% | 126,669 | $-49,910 | Down ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $11,816,721 | 1.01% | 121,222 | $-2,629,016 | Down ×1 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $11,713,901 | 1.01% | 249,020 | $7,833,410 | Up ×1 | ||
| GILD Gilead Sciences, Inc. - Common Stock | $11,479,000 | 0.98% | 90,858 | ||||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $11,275,097 | 0.97% | 101,550 | $-606,831 | Down ×1 | ||
| HSIC Henry Schein, Inc. - Common Stock | $11,227,009 | 0.96% | 134,423 | $-57,493 | Down ×1 | ||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $10,732,177 | 0.92% | 131,667 | $6,701,884 | Up ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $10,192,229 | 0.87% | 326,047 | $1,693,584 | Down ×1 | ||
| TFX Teleflex Incorporated Common Stock | $10,103,786 | 0.87% | 79,708 | ||||
| VKTX Viking Therapeutics, Inc. - Common Stock | $9,960,423 | 0.85% | 255,330 | $1,398,954 | Down ×1 | ||
| BTSG BrightSpring Health Services, Inc. - Common Stock | $9,897,082 | 0.85% | 141,914 | $1,914,738 | Down ×1 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $9,624,241 | 0.83% | 224,289 | $2,589,342 | Up ×2 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $9,484,803 | 0.81% | 268,008 | $3,738,549 | Up ×1 | ||
| CGON CG Oncology, Inc. - Common stock | $9,114,720 | 0.78% | 128,286 | $-2,115,084 | Down ×1 | ||
| AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | $8,321,177 | 0.71% | 480,715 | $-3,239,916 | Down ×2 | ||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $8,002,469 | 0.69% | 1,210,661 | $4,086,563 | Up ×1 | ||
| COR Cencora, Inc. Common Stock | $7,951,738 | 0.68% | 28,100 | Call option | Up ×1 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $7,755,064 | 0.67% | 65,196 | ||||
| KOD Kodiak Sciences Inc - Common Stock | $7,531,552 | 0.65% | 193,315 | $3,158,464 | Up ×1 | ||
| ABT Abbott Laboratories Common Stock | $7,461,550 | 0.64% | 82,230 | $-6,956,603 | Down ×1 | ||
| WST West Pharmaceutical Services, Inc. Common Stock | $7,443,147 | 0.64% | 20,733 | ||||
| TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | $7,120,093 | 0.61% | 444,173 | Up ×1 | |||
| HNGE Hinge Health, Inc. Class A Common Stock | $6,877,380 | 0.59% | 82,860 | Up ×1 | |||
| ARQT Arcutis Biotherapeutics, Inc. - Common stock | $6,347,049 | 0.54% | 242,069 | ||||
| IART Integra LifeSciences Holdings Corporation - Common Stock | $6,263,478 | 0.54% | 348,746 | Up ×1 | |||
| ILMN Illumina, Inc. - Common Stock | $6,161,083 | 0.53% | 35,040 | $2,602,690 | Up ×1 | ||
| MGTX MeiraGTx Holdings plc - Ordinary Shares | $6,150,914 | 0.53% | 455,286 | Up ×1 | |||
| OCS Oculis Holding AG - Ordinary shares | $6,047,903 | 0.52% | 436,042 | Up ×1 | |||
| NTRA Natera, Inc. - Common Stock | $5,992,802 | 0.51% | 22,077 | $-6,007,398 | Down ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $5,765,361 | 0.49% | 43,264 | $2,796,325 | Up ×1 | ||
| CNC Centene Corporation Common Stock | $5,661,558 | 0.49% | 88,200 | Put option | Up ×1 | ||
| GH Guardant Health, Inc. - Common Stock | $5,506,251 | 0.47% | 36,701 | Up ×1 | |||
| CELC Celcuity Inc. - Common Stock | $5,456,456 | 0.47% | 52,155 | ||||
| BLTE Belite Bio, Inc - American Depositary Shares | $5,359,140 | 0.46% | 34,803 | $-4,116,698 | Down ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $4,913,489 | 0.42% | 91,550 | $-1,178,172 | Down ×1 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $4,690,137 | 0.40% | 152,129 | Up ×1 | |||
| CRL Charles River Laboratories International, Inc. Common Stock | $4,251,632 | 0.36% | 18,747 | Up ×1 | |||
| ELAN Elanco Animal Health Incorporated Common Stock | $4,244,954 | 0.36% | 172,489 | ||||
| ARGX argenx SE - American Depositary Shares | $4,158,265 | 0.36% | 4,482 | $846,581 | Down ×1 | ||
| BIO Bio-Rad Laboratories, Inc. Class A Common Stock | $4,109,072 | 0.35% | 13,995 | Up ×1 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $4,103,145 | 0.35% | 46,217 | Up ×1 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $3,917,599 | 0.34% | 70,971 | $1,771,563 | Down ×3 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $3,691,920 | 0.32% | 31,536 | Up ×1 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $3,504,369 | 0.30% | 192,442 | $272,930 | Down ×1 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $3,503,384 | 0.30% | 247,589 | $-4,056,673 | Down ×1 | ||
| HCA HCA Healthcare, Inc. Common Stock | $3,234,138 | 0.28% | 8,295 | $-3,084,089 | Down ×5 | ||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $2,943,082 | 0.25% | 122,221 | $-821,380 | Down ×1 | ||
| DNLI Denali Therapeutics Inc. - Common Stock | $2,596,846 | 0.22% | 100,966 | Up ×1 | |||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $2,588,705 | 0.22% | 118,422 | $-3,134,986 | Down ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $2,580,852 | 0.22% | 143,700 | $561,529 | Down ×1 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $2,554,042 | 0.22% | 40,579 | $-3,073,812 | Down ×1 | ||
| OM Outset Medical, Inc. - Common Stock | $2,514,767 | 0.22% | 582,122 | $231,388 | Down ×1 | ||
| OMDA Omada Health, Inc. - Common Stock | $2,512,002 | 0.22% | 114,442 | Up ×1 | |||
| ERAS Erasca, Inc. - Common Stock | $2,456,492 | 0.21% | 134,088 | ||||
| COR Cencora, Inc. Common Stock | $2,089,807 | 0.18% | 7,385 | ||||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $2,073,570 | 0.18% | 207,357 | Up ×1 | |||
| OMCL Omnicell, Inc. - Common Stock | $2,036,141 | 0.17% | 49,040 | Up ×1 | |||
| CVRX CVRx, Inc. - Common Stock | $1,899,600 | 0.16% | 369,572 | Up ×1 | |||
| HIMS Hims & Hers Health, Inc. Class A Common Stock | $1,714,570 | 0.15% | 49,454 | ||||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $1,684,038 | 0.14% | 62,418 | $-2,181,082 | Down ×1 | ||
| TECX Tectonic Therapeutic, Inc. - Common Stock | $1,568,566 | 0.13% | 45,631 | $142,719 | Down ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $1,215,800 | 0.10% | 26,396 | $518,718 | Down ×1 | ||
| RZLT Rezolute, Inc. - Common Stock (NV) | $661,903 | 0.06% | 127,289 | $269,289 | Down ×3 | ||
| CRBU Caribou Biosciences, Inc. - Common Stock | $624,249 | 0.05% | 354,687 | $-1,195,546 | Down ×1 | ||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: K08588103) | $62,191,369 | 233,171 | 5.34% |
| HUM | $37,487,638 | 94,375 | 3.22% |
| MTD | $17,047,093 | 13,344 | 1.46% |
| MRK | $16,334,663 | 127,118 | 1.40% |
| CYTK | $16,329,730 | 191,686 | 1.40% |
| LNTH | $16,241,949 | 146,403 | 1.39% |
| CVS | $14,219,927 | 137,457 | 1.22% |
| GILD | $11,479,000 | 90,858 | 0.98% |
| TFX | $10,103,786 | 79,708 | 0.87% |
| COR | $7,951,738 | 28,100 | 0.68% |
| IRTC | $7,755,064 | 65,196 | 0.67% |
| WST | $7,443,147 | 20,733 | 0.64% |
| TAK | $7,120,093 | 444,173 | 0.61% |
| HNGE | $6,877,380 | 82,860 | 0.59% |
| ARQT | $6,347,049 | 242,069 | 0.54% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| THC | Trimmed | -272K | -$51.5M |
| PEN | Trimmed | -80K | -$26.9M |
| UNH | Bought more | +30K | +$21.0M |
| ICLR | Bought more | +79K | +$17.3M |
| LLY | Trimmed | -27K | -$13.4M |
| RVMD | Bought more | +2K | +$13.1M |
| SYK | Bought more | +35K | +$10.6M |
| WAT | Bought more | +20K | +$10.6M |
| AXSM | Trimmed | -45K | +$9.1M |
| OSCR | Bought more | +19K | +$9.1M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| IEF | March 31, 2025 | 1,000,000 | $92,450,000 | |
| XBI | Dec. 31, 2025 | 717,400 | $71,883,480 | No longer tracked |
| XLV | June 30, 2025 | 429,700 | $62,740,497 | No longer tracked |
| VRTX | June 30, 2025 | 126,989 | $61,566,807 | 22.8% |
| XBI | June 30, 2026 | 455,300 | $58,155,469 | No longer tracked |
| MCK | Dec. 31, 2025 | 72,313 | $55,864,685 | 4.4% |
| ASND | June 30, 2026 | 174,434 | $39,898,289 | -3.3% |
| ELV | June 30, 2025 | 88,222 | $38,373,041 | 2.8% |
| XLV | June 30, 2026 | 238,900 | $35,025,129 | No longer tracked |
| DHR | Sept. 30, 2025 | 161,413 | $31,885,524 | 8.0% |
| UNH | Sept. 30, 2025 | 99,623 | $31,079,387 | 12.2% |
| HUM | Dec. 31, 2025 | 113,648 | $29,567,800 | 49.9% |
| UHS | June 30, 2025 | 155,520 | $29,222,208 | -3.6% |
| NVO | March 31, 2025 | 334,900 | $28,808,098 | -32.7% |
| DXCM | March 31, 2025 | 328,763 | $25,567,899 | 31.0% |
| MOH | Sept. 30, 2025 | 85,739 | $25,541,648 | 3.6% |
| COR | Dec. 31, 2025 | 80,493 | $25,156,477 | -6.2% |
| ALNY | Sept. 30, 2025 | 72,220 | $23,550,220 | -49.6% |
| GKOS | June 30, 2026 | 215,685 | $23,220,647 | 32.2% |
| ADMA | March 31, 2026 | 1,270,894 | $23,181,107 | 8.9% |
| NBIX | March 31, 2025 | 166,803 | $22,768,610 | 39.3% |
| IJH | March 31, 2025 | 347,637 | $21,661,261 | No longer tracked |
| CNTA | June 30, 2026 | 528,224 | $20,981,057 | No longer tracked |
| BDX | June 30, 2025 | 91,571 | $20,975,253 | 39.4% |
| MDT | March 31, 2026 | 213,796 | $20,537,244 | 6.3% |
| MRK | March 31, 2026 | 187,834 | $19,771,407 | 26.1% |
| IQV | June 30, 2025 | 111,854 | $19,719,860 | 62.5% |
| ELV | Dec. 31, 2025 | 60,776 | $19,637,941 | 14.0% |
| RSP | March 31, 2025 | 108,041 | $18,932,024 | No longer tracked |
| NTRA | Dec. 31, 2025 | 115,596 | $18,607,488 | 41.9% |
| UTHR | March 31, 2025 | 52,500 | $18,524,100 | 70.7% |
| KWEB | March 31, 2025 | 615,674 | $18,002,308 | No longer tracked |
| CAH | March 31, 2025 | 148,173 | $17,524,421 | 67.4% |
| XBI | March 31, 2025 | 179,100 | $16,129,746 | No longer tracked |
| MASI | Sept. 30, 2025 | 94,451 | $15,888,547 | No longer tracked |
| BSX | Dec. 31, 2025 | 150,648 | $14,707,764 | -48.2% |
| SPY | Dec. 31, 2025 | 21,210 | $14,129,678 | No longer tracked |
| HOLX | Sept. 30, 2025 | 211,986 | $13,813,008 | No longer tracked |
| IWM | Dec. 31, 2025 | 56,700 | $13,719,132 | No longer tracked |
| XRT | June 30, 2025 | 193,671 | $13,380,729 | No longer tracked |
| NEO | June 30, 2026 | 1,784,552 | $13,241,376 | 11.2% |
| UHS | March 31, 2026 | 57,409 | $12,516,310 | -2.5% |
| TFX | March 31, 2026 | 102,395 | $12,496,286 | 12.8% |
| MRUS | Dec. 31, 2025 | 130,742 | $12,309,359 | No longer tracked |
| IWM | March 31, 2025 | 54,800 | $12,108,608 | No longer tracked |
| AKRO | Dec. 31, 2025 | 248,079 | $11,778,791 | No longer tracked |
| SYK | March 31, 2025 | 32,349 | $11,647,257 | -11.2% |
| VEEV | March 31, 2025 | 55,383 | $11,644,276 | 6.9% |
| SNDX | June 30, 2025 | 926,424 | $11,381,119 | 111.5% |
| REGN | Dec. 31, 2025 | 19,890 | $11,183,550 | 8.5% |
| IRTC | Dec. 31, 2025 | 64,998 | $11,179,006 | -27.8% |
| AZN | June 30, 2025 | 150,200 | $11,039,700 | 136.8% |
| TMO | June 30, 2025 | 21,897 | $10,895,947 | 53.0% |
| BMRN | Sept. 30, 2025 | 178,319 | $9,802,195 | 24.9% |
| DXCM | June 30, 2026 | 149,734 | $9,403,295 | 32.8% |
| TERN | June 30, 2026 | 172,962 | $9,118,557 | No longer tracked |
| TEVA | March 31, 2025 | 397,024 | $8,750,409 | 141.8% |
| ISRG | March 31, 2026 | 15,410 | $8,727,608 | -19.0% |
| GILD | March 31, 2026 | 71,018 | $8,716,749 | 3.9% |
| VRNA | Dec. 31, 2025 | 80,416 | $8,581,191 | No longer tracked |
| CVS | March 31, 2026 | 107,767 | $8,552,389 | 30.3% |
| SNY | March 31, 2026 | 176,413 | $8,548,974 | -5.3% |
| IQV | March 31, 2026 | 37,852 | $8,532,219 | 50.2% |
| SLNO | June 30, 2026 | 248,180 | $8,309,066 | No longer tracked |
| CNC | June 30, 2025 | 135,398 | $8,220,013 | 18.2% |
| ABBV | Sept. 30, 2025 | 40,782 | $7,569,955 | 13.9% |
| SPY | March 31, 2025 | 12,427 | $7,283,216 | No longer tracked |
| VEEV | March 31, 2026 | 32,489 | $7,252,519 | 41.0% |
| TEVA | Dec. 31, 2025 | 356,818 | $7,207,724 | 19.1% |
| BLLN | June 30, 2026 | 88,069 | $6,952,167 | -20.7% |
| ARQT | Dec. 31, 2025 | 360,460 | $6,794,671 | -13.5% |
| CAH | June 30, 2026 | 31,941 | $6,749,453 | -2.9% |
| ALGN | March 31, 2026 | 42,304 | $6,605,770 | -7.3% |
| ALHC | June 30, 2026 | 359,826 | $6,340,134 | -45.0% |
| BPMC | Sept. 30, 2025 | 48,444 | $6,209,552 | No longer tracked |
| PSNL | June 30, 2026 | 870,097 | $5,542,518 | 26.0% |
| WST | Dec. 31, 2025 | 18,365 | $4,817,690 | 28.2% |
| BHVN | June 30, 2025 | 197,307 | $4,743,260 | 1.0% |
| AZN | Dec. 31, 2025 | 61,795 | $4,740,912 | 80.0% |
| ELAN | March 31, 2026 | 207,311 | $4,691,448 | 0.5% |
| MOH | March 31, 2026 | 22,802 | $3,957,059 | 48.7% |
| MDLN | June 30, 2026 | 86,777 | $3,861,577 | -16.4% |
| BNTX | March 31, 2025 | 33,109 | $3,772,771 | 25.9% |
| PMVP | June 30, 2025 | 3,301,942 | $3,599,117 | 25.0% |
| ITCI | March 31, 2025 | 40,610 | $3,391,747 | No longer tracked |
| SRPT | June 30, 2025 | 50,809 | $3,242,630 | 14.4% |
| ELVN | Dec. 31, 2025 | 156,463 | $3,202,798 | 285.5% |
| XENE | June 30, 2025 | 92,236 | $3,094,518 | 92.3% |
| INSM | March 31, 2025 | 43,774 | $3,022,157 | 64.4% |
| TGTX | March 31, 2025 | 98,674 | $2,970,087 | 39.9% |
| FTRE | March 31, 2026 | 165,439 | $2,853,823 | 90.7% |
| IOBT | Sept. 30, 2025 | 1,972,073 | $2,741,181 | No longer tracked |
| ADAPY | March 31, 2025 | 4,871,969 | $2,624,530 | No longer tracked |
| ALKS | March 31, 2025 | 80,719 | $2,321,478 | 45.6% |
| JAZZ | March 31, 2025 | 17,597 | $2,167,071 | 101.7% |
| LQDA | Dec. 31, 2025 | 76,300 | $1,735,062 | 103.0% |
| GMED | June 30, 2026 | 16,923 | $1,458,086 | 7.9% |
| ERAS | Sept. 30, 2025 | 1,072,224 | $1,361,724 | 708.7% |
| CAPR | June 30, 2025 | 140,681 | $1,335,063 | -30.3% |
| HIMS | Dec. 31, 2025 | 22,915 | $1,299,739 | -0.2% |
| MGX | June 30, 2025 | 885,803 | $1,204,692 | -16.9% |
| SWTX | June 30, 2025 | 26,437 | $1,166,665 | No longer tracked |
| KROS | June 30, 2025 | 104,323 | $1,063,051 | -18.1% |
| ACLX | June 30, 2025 | 15,488 | $1,016,013 | No longer tracked |
| MNMD | Dec. 31, 2025 | 75,138 | $885,877 | No longer tracked |
| IRON | March 31, 2026 | 11,002 | $873,669 | 22.4% |
| GBIO | March 31, 2025 | 787,914 | $835,189 | No longer tracked |
| HOWL | Dec. 31, 2025 | 401,110 | $790,187 | 43.0% |
| VERV | June 30, 2025 | 155,495 | $710,612 | No longer tracked |
| SGMT | Sept. 30, 2025 | 90,000 | $685,800 | 49.1% |
| BLUE | March 31, 2025 | 75,758 | $631,822 | No longer tracked |
| CELC | June 30, 2025 | 53,349 | $539,358 | 590.4% |
| IOVA | June 30, 2025 | 132,152 | $440,066 | 422.4% |
| TSBX | June 30, 2025 | 932,348 | $382,263 | No longer tracked |
| BOLD | June 30, 2025 | 240,513 | $363,175 | 195.0% |
| NPCE | March 31, 2026 | 11,329 | $174,920 | 5.6% |
| TMCI | March 31, 2026 | 50,000 | $122,500 | 235.4% |